Genetic Signatures reported AUD127.64M in Ordinary Share Capital for its fiscal semester ending in December of 2024.


Ordinary Share Capital Change Date
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Pacific Edge NZD 294.46M 58K Sep/2024
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
Starpharma Holdings AUD 240.75M 0 Dec/2024
Telix Pharmaceuticals AUD 334.72M 252.68M Dec/2024